Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Oct 13;85(15):1283-92.
doi: 10.1212/WNL.0000000000002016. Epub 2015 Sep 9.

Large-scale assessment of polyglutamine repeat expansions in Parkinson disease

Lisa Wang  1 , Jan O Aasly  1 , Grazia Annesi  1 , Soraya Bardien  1 , Maria Bozi  1 , Alexis Brice  1 , Jonathan Carr  1 , Sun J Chung  1 , Carl Clarke  1 , David Crosiers  1 , Angela Deutschländer  1 , Gertrud Eckstein  1 , Matthew J Farrer  1 , Stefano Goldwurm  1 , Gaetan Garraux  1 , Georgios M Hadjigeorgiou  1 , Andrew A Hicks  1 , Nobutaka Hattori  1 , Christine Klein  1 , Beom Jeon  1 , Yun J Kim  1 , Suzanne Lesage  1 , Juei-Jueng Lin  1 , Timothy Lynch  1 , Peter Lichtner  1 , Anthony E Lang  1 , Vincent Mok  1 , Barbara Jasinska-Myga  1 , George D Mellick  1 , Karen E Morrison  1 , Grzegorz Opala  1 , Lasse Pihlstrøm  1 , Peter P Pramstaller  1 , Sung S Park  1 , Aldo Quattrone  1 , Ekaterina Rogaeva  1 , Owen A Ross  1 , Leonidas Stefanis  1 , Joanne D Stockton  1 , Peter A Silburn  1 , Jessie Theuns  1 , Eng K Tan  1 , Hiroyuki Tomiyama  1 , Mathias Toft  1 , Christine Van Broeckhoven  1 , Ryan J Uitti  1 , Karin Wirdefeldt  1 , Zbigniew Wszolek  1 , Georgia Xiromerisiou  1 , Kuo-Chu Yueh  1 , Yi Zhao  1 , Thomas Gasser  1 , Demetrius M Maraganore  1 , Rejko Krüger  1 , Manu Sharma  2 ; GEO-PD Consortium
Collaborators, Affiliations

Large-scale assessment of polyglutamine repeat expansions in Parkinson disease

Lisa Wang et al. Neurology. .

Abstract

Objectives: We aim to clarify the pathogenic role of intermediate size repeat expansions of SCA2, SCA3, SCA6, and SCA17 as risk factors for idiopathic Parkinson disease (PD).

Methods: We invited researchers from the Genetic Epidemiology of Parkinson's Disease Consortium to participate in the study. There were 12,346 cases and 8,164 controls genotyped, for a total of 4 repeats within the SCA2, SCA3, SCA6, and SCA17 genes. Fixed- and random-effects models were used to estimate the summary risk estimates for the genes. We investigated between-study heterogeneity and heterogeneity between different ethnic populations.

Results: We did not observe any definite pathogenic repeat expansions for SCA2, SCA3, SCA6, and SCA17 genes in patients with idiopathic PD from Caucasian and Asian populations. Furthermore, overall analysis did not reveal any significant association between intermediate repeats and PD. The effect estimates (odds ratio) ranged from 0.93 to 1.01 in the overall cohort for the SCA2, SCA3, SCA6, and SCA17 loci.

Conclusions: Our study did not support a major role for definite pathogenic repeat expansions in SCA2, SCA3, SCA6, and SCA17 genes for idiopathic PD. Thus, results of this large study do not support diagnostic screening of SCA2, SCA3, SCA6, and SCA17 gene repeats in the common idiopathic form of PD. Likewise, this largest multicentered study performed to date excludes the role of intermediate repeats of these genes as a risk factor for PD.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Forest plot of effect sizes of SCA2, SCA3, SCA6, and SCA17 loci in the overall cohort
Boxes indicate the summary effect estimate. Germany site is a combination of Deutschländer, Klein, and Gasser sites. Axis scaled in relation to CIs. CI = confidence interval; OR = odds ratio; RE = random effects.
Figure 2
Figure 2. Forest plot of SCA2, SCA3, SCA6, and SCA17 loci in the Asian population
Boxes indicate the summary effect estimate. Germany site is a combination of Deutschländer, Klein, and Gasser sites. Axis scaled in relation to CIs. CI = confidence interval; OR = odds ratio; RE = random effects.
Figure 3
Figure 3. Forest plot showing the comparison of effect of SCA2, SCA3, SCA6, and SCA17 loci in the Caucasian population
Boxes indicate the summary effect estimate. Germany site is a combination of Deutschländer, Klein, and Gasser sites. Axis scaled in relation to CIs. CI = confidence interval; OR = odds ratio; RE = random effects.
See this image and copyright information in PMC

Comment in

References

    1. Schols L, Bauer P, Schmidt T, Schulte T, Riess O. Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol 2004;3:291–304. - PubMed
    1. Orr HT, Zoghbi HY. Trinucleotide repeat disorders. Annu Rev Neurosci 2007;30:575–621. - PubMed
    1. Ross OA, Rutherford NJ, Baker M, et al. Ataxin-2 repeat-length variation and neurodegeneration. Hum Mol Genet 2011;20:3207–3212. - PMC - PubMed
    1. Simon-Sanchez J, Hanson M, Singleton A, et al. Analysis of SCA-2 and SCA-3 repeats in parkinsonism: evidence of SCA-2 expansion in a family with autosomal dominant Parkinson's disease. Neurosci Lett 2005;382:191–194. - PubMed
    1. Gwinn-Hardy K, Singleton A, O'Suilleabhain P, et al. Spinocerebellar ataxia type 3 phenotypically resembling Parkinson disease in a black family. Arch Neurol 2001;58:296–299. - PubMed

Publication types

LinkOut - more resources